Signature Alliance Group Bhd maintains a relatively strong liquidity position, with a liquidity FPT of 0.19, indicating a low debt-to-equity ratio of 0.19. The company's return on equity (ROE) of 1…
Samorita Hospital Ltd has a basic and diluted share count of 21.8 million shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. How…
TGTR.TA has a debt-to-equity ratio of 1.24, indicating a moderate level of leverage. The company's liquidity position is characterized as medium, with a current ratio of 1.32, suggesting it can cov…
TTI.V maintains a strong liquidity position with $1.62 billion in cash and equivalents, significantly exceeding its total equity of $574.38 million, indicating a conservative capital structure with…
Upside Gold Corp has a capital structure characterized by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. The company's liquidity position is reflected in a current ratio o…
Unified Data-Tech Solutions Limited has a basic and diluted share count of 20,090,100 shares outstanding, indicating no immediate dilution pressure from share issuance. However, liquidity risk coul…
Viking Therapeutics Inc is a biotechnology company operating within the Health Care sector, currently generating no revenue while incurring significant operating losses. The company is classified u…
Chongqing Sansheng Industrial Co Ltd has a market capitalization of 2.96 billion CNY, with a market price of 4.33 CNY per share. The company has 684.1 million shares outstanding, with no dilution o…
The company maintains a strong liquidity position, with cash and equivalents amounting to CNY 251.5 million, significantly exceeding its total liabilities of CNY 194.9 million. The debt-to-equity r…
Golden Throat Holdings Group Co Ltd has a market capitalization of 2.54 billion CNY, with a market price of 3.43 CNY per share. The company has no dilution risk, as the number of basic and diluted…
The company maintains a debt-to-equity ratio of 0.59, indicating a moderate reliance on debt financing relative to equity. Its liquidity position is assessed as medium, with a negative net cash pos…
Anya Biopharm Inc has a fully diluted share count of 49,101,000, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk from stock options or convert…
The company maintains a strong liquidity position, with a current ratio of 9.32, indicating a significant ability to meet short-term obligations. The absence of long-term debt and a debt-to-equity…
BIOE.VI has an identical number of basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. However, the company's liquidity position could no…
Car & General (Kenya) PLC has a fully diluted share count of 80,206,616, with no additional shares outstanding in the diluted structure, indicating no immediate dilution pressure from stock options…
Regentis Biomaterials Ltd operates with a capital structure that is currently opaque due to the absence of a financial snapshot or valuation data. Without liquidity metrics such as cash reserves, d…
MEDL.SI has a negative equity position of -5,479,950 MYR, indicating a significant financial challenge. The company's liquidity is further strained with a current ratio of 0.13, suggesting it has l…
MLIFS.EUA has an equal number of basic and diluted shares outstanding, with 8,697,107 shares in each category, indicating no dilution from stock options or convertible securities. However, liquidit…
MTMH.JK has a debt-to-equity ratio of 0.52, indicating a moderate level of leverage, and a current ratio of 0.43, suggesting potential liquidity constraints. The company's free cash flow is negativ…
NTV.BK maintains a strong liquidity position, as evidenced by a current ratio of 5.78, indicating that the company has significantly more current assets than current liabilities. The company also h…
Nyrada's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. This…
OBAT.JK maintains a strong liquidity position, with a current ratio of 6.65, indicating a robust ability to meet short-term obligations. The company's liquidity_fpt score further supports this, sho…
Premium Healthcare Group has a basic and diluted share count of 23.63 billion shares, indicating no immediate dilution pressure from share issuance. The absence of a liquidity risk assessment sugge…
Rameda's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source documents. This…
RPG Life Sciences has a revenue of INR 1,654.20 million and a net income of INR 267.60 million, indicating a net margin of 16.18%. The company's operating income of INR 337.80 million suggests a st…
RSGK.JK maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.18, indicating a low reliance on debt financing. The company's liquidity position is characterized as med…
SOTA.NS has a debt-to-equity ratio of 0.82, indicating a moderate reliance on debt financing, and a current ratio of 1.35, suggesting it has sufficient short-term assets to cover its liabilities. H…
TOPV.KL maintains a debt-to-equity ratio of 0.65, indicating a moderate level of leverage, and a current ratio of 4.1, suggesting strong short-term liquidity. However, the company's free cash flow…
Sun Hing Vision Group Holdings Ltd has a basic and diluted share count of 262,778,286, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed…
Tian An Medicare Ltd has a basic capital structure with no dilution risk identified, as the number of basic and diluted shares outstanding is identical at 1,080,530,457. However, liquidity risk cou…
The company's capital structure is characterized by a market price of 0.29 HKD per share, resulting in a market capitalization of 1,185,644,304.44 HKD. The shares outstanding are 4,088,428,636 for…
Shanghai Kaibao Pharmaceutical Co Ltd maintains a strong liquidity position, with a current ratio of 13.41, indicating that the company holds significantly more current assets than current liabilit…
The company's capital structure is highly leveraged, with total liabilities of KRW 421.5 billion and total equity of -KRW 354.0 billion, resulting in a debt-to-equity ratio of -0.9. The company has…
A-Spine Asia has a market capitalization of TWD 390.66 million, with a market price of TWD 29 per share. The company has 13.47 million shares outstanding, with no dilution observed between basic an…
Republic Healthcare Ltd has a market capitalization of SGD 64.9 million, with a market price of SGD 0.104 per share. The company has 624 million shares outstanding, with no dilution from potential…
Balsm Alofoq Medical Company CJSC has a basic and diluted share count of 2.5 million shares outstanding, indicating no immediate dilution pressure from share issuance. However, the liquidity risk c…
ASIT.DH's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no mention of going-concern language in the source documents. This lack of data preve…
AVCN.TO has a debt-free capital structure, as evidenced by a debt-to-equity ratio of 0.0, indicating no long-term debt obligations. However, the company's liquidity position is weak, with a current…
Coiled Therapeutics has a market capitalization of £481.2 million, with a market price of £11.3 per share. The company has no dilution risk, as the number of basic and diluted shares outstanding is…
Cellyan Biotechnology has a fully diluted share count of 23,499,986 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or conver…
The company maintains a relatively strong liquidity position, with a current ratio of 2.58, indicating that it has more than twice the current assets to cover its current liabilities. However, the…
OFSA3.SA maintains a capital structure with a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of…
The company's capital structure is characterized by a negative total equity of -574,000 AUD and a debt-to-equity ratio of -10.65, indicating a highly leveraged position with significant long-term d…
The company has a market capitalization of $369.25 billion, with a market price of $28,500 per share. The shares outstanding are 12,956,030 for both basic and diluted shares, indicating no dilution…
Green LifeScience maintains a strong liquidity position, with a current ratio of 3.21 and cash and equivalents of KRW 5.65 billion, which exceeds its short-term obligations. The company's debt-to-e…
Ab&B Bio Tech Co Ltd JS has a fully diluted share count of 393,442,600 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or converti…
Zhejiang Tailin Bioengineering Co Ltd has a market capitalization of 2.76 billion CNY, with a market price of 22.8 CNY per share. The company has no dilution risk, as the number of basic and dilute…
The company maintains a strong liquidity position, with a current ratio of 11.62, indicating a high ability to meet short-term obligations. Free cash flow stands at 101.38 million CNY, and operatin…
4747.TWO maintains a strong liquidity position, with a current ratio of 3.79 and cash and equivalents of TWD 567 million, which is well above the industry median. The company's liquidity_fpt score…
Innovacell Inc has a market capitalization of ¥29.35 billion, with a market price of ¥650 per share, and no dilution risk based on the current share count of 45.15 million shares outstanding, both…
The company's capital structure is characterized by a high level of equity, with total equity of 441,592,000 TWD and total liabilities of 23,644,000 TWD, resulting in a debt-to-equity ratio of 0.01…
Formosa Pharmaceuticals Inc has a current ratio of 4.58, indicating strong short-term liquidity, but its operating cash flow is negative at -53,728,000 TWD, and free cash flow is also negative at -…
Qomel Co has a fully diluted share count of 7,000,000 shares, with no difference between basic and diluted shares outstanding, indicating no immediate dilution pressure from stock options or conver…
Allianca Saude e Participacoes SA has a debt-to-equity ratio of 0.87, indicating a moderate level of leverage, and a current ratio of 1.04, suggesting limited short-term liquidity cushion. The comp…
Hamlet BioPharma AB has a strong liquidity position, as evidenced by a current ratio of 7.81, indicating that the company holds significantly more current assets than current liabilities. The compa…
Lyka's capital structure shows a debt-to-equity ratio of 0.38, indicating a relatively conservative leverage position compared to the industry median of 0.55. The company's liquidity is assessed as…
MATERNUS-Kliniken-AG has a basic and diluted share count of 20,970,000, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be assessed due to the absen…
Vaidya Sane Ayurved Laboratories Ltd has a basic capital structure with no dilution risk, as the number of basic and diluted shares outstanding is identical at 10,520,350. However, liquidity risk c…
Samyang Biopharm Corp has a market capitalization of 485.18 billion KRW, with a market price of 65,300 KRW per share. The company has no dilution risk, as basic and diluted shares outstanding are e…
Green International Holdings Ltd has a market capitalization of HKD 402.54 million, with a market price of HKD 0.61 per share. The company has no dilution risk, as basic and diluted shares outstand…
Holy Stone Healthcare's capital structure is characterized by a lack of detailed liquidity metrics, as no balance-sheet inputs are available and no going-concern language is present in the source d…
Winston Medical Supply Co Ltd has a market capitalization of TWD 1,136,328,900, with a market price of TWD 61.7 per share. The company has 18,417,000 basic and diluted shares outstanding, indicatin…
Acer Medical Inc has a market capitalization of TWD 1.45 billion, with a market price of TWD 95.5 per share. The company has 15.23 million shares outstanding, with no dilution observed between basi…
Han Biomedical Inc has a market capitalization of TWD 683,565,750, with a market price of TWD 31.05 per share. The company has 22,015,000 basic and diluted shares outstanding, indicating no immedia…
Aptus Pharma Ltd has a fully diluted share count of 6,860,000 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible…
HeraMED operates with a fully diluted share count of 1,154,986,602 shares, with no additional dilution observed in the current financial snapshot. The company's market capitalization is AUD 42.73 m…
Idna Genomics has a fully diluted share count of 2,760,333 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible sec…
Libra Infusions Ltd has a fully diluted share count of 2,252,880 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertib…
JMolner AS has a fully diluted share count of 1,686,001 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securi…
Renalytix has 437,018,680 basic shares outstanding, with no dilution from potential share issuance, as the diluted share count is equal to the basic count. The company's market price is $1.80, resu…
Tiziana Life Sciences Ltd has a market capitalization of $184.53 million, with a current market price of $1.45 per share. The company has 127,259,131 basic and diluted shares outstanding, indicatin…
Jiangsu Hengrui Pharmaceuticals Co Ltd operates in the pharmaceuticals industry, generating revenue through the development and sale of pharmaceutical products. The company is classified within the…
Innovent Biologics Inc is a biopharmaceutical company that generates revenue through the development and commercialization of innovative biological drugs. The company is classified in the Pharmaceu…
Wenzhou Kangning Hospital Co Ltd has a fully diluted share count of 72,358,900 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock option…
Beijing Airdoc Technology Co Ltd has a market capitalization of CNY 1,069,799,608.11, with a market price of CNY 10.47 per share. The company has 102,177,613 basic and diluted shares outstanding, i…
WuXi Biologics (Cayman) Inc operates as a contract development and manufacturing organization (CDMO) in the life sciences sector, generating revenue through the provision of biologics development a…
WuXi AppTec Co Ltd operates as a pharmaceutical services provider within the Healthcare sector, generating revenue through life sciences tools and services activities. The company is classified in…
HealthyWay Inc has a market capitalization of 3.36 billion CNY, with a market price of 3.84 CNY per share. The company has 874.27 million shares outstanding, with no dilution observed between basic…
3118.TWO maintains a strong liquidity position, with a current ratio of 1.82 and cash and equivalents amounting to TWD 210.3 million. The company's low debt-to-equity ratio of 0.01 indicates a cons…
Tien Liang Biotech has a debt-to-equity ratio of 1.26, indicating a moderate level of leverage, and a current ratio of 0.4, suggesting potential liquidity constraints. The company's free cash flow…
PlexBio's capital structure and liquidity position cannot be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. This lack of data prevents a mean…
Spirit Scientific's capital structure and liquidity position remain opaque due to the absence of balance-sheet inputs and no going-concern language in source documents, preventing a liquidity risk…
Grand Brilliance Group Holdings Ltd has a fully diluted share count of 800 million, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options o…
The company maintains a debt-to-equity ratio of 0.55, indicating a moderate level of leverage, and a current ratio of 6.26, suggesting strong short-term liquidity. However, the company's free cash…
Aclaris Therapeutics Inc operates in the Health Care sector, specifically within Pharmaceuticals, though its specific business activity remains unclassified in the available data. The company is cl…
Active Biotech AB is a biotechnology company operating within the Health Care sector, currently generating no revenue while incurring operating losses. The company is classified in the Biotechnolog…
20/20 Biolabs Inc has a market capitalization of $14.46 million and a market price of $1.38 per share, based on the latest valuation data. The company has no dilution risk in the near term, as the…
Bayer AG is a global healthcare company operating in the pharmaceuticals and agricultural sciences sectors, generating revenue through the sale of prescription medicines and crop protection product…
CytomX Therapeutics Inc is a biotechnology company that develops T-cell engaging bispecific therapies through strategic alliances with major pharmaceutical partners including Amgen, Bristol Myers S…
Cytokinetics Inc is a biotechnology company focused on the discovery and development of novel therapeutics, primarily in the cardiovascular and neuromuscular spaces, generating revenue through lice…
Encompass Health Corp operates as a health care provider and services company, generating revenue through inpatient rehabilitation and post-acute care services. The company is classified within the…
Fulgent Genetics Inc. operates as a clinical laboratory providing diagnostic testing services, including next-generation sequencing and immunohistochemistry, relying on key suppliers such as Illumi…
MeiraGTx Holdings PLC is a biotechnology company operating in the Health Care sector, primarily generating revenue through the commercialization of its ophthalmology product, while currently incurr…
Nutex Health Inc operates as a healthcare provider and services company, generating revenue through its healthcare operations. The company is classified under the Health Care sector and Health Care…
OCS.O is a health care company classified within the pharmaceuticals industry, though its specific operational activities and revenue generation mechanisms are not detailed in the available data. T…
Perseverance Metals Inc has a market capitalization of CAD 25,868,505.7 and a market price of CAD 0.67 per share, with 38,609,710 basic and diluted shares outstanding. The company's liquidity risk…
PRAX.O is a biotechnology company within the Health Care sector that currently reports zero revenue and operates with a negative operating income, relying on equity financing and cash reserves to f…
Prime Medicine, Inc. is a biotechnology company operating within the Health Care sector, generating minimal revenue of $4.6 million while incurring significant operating losses of $208.4 million. T…
RadNet Inc operates in the healthcare sector, specifically within the Pharmaceuticals & Medical Research business sector, generating revenue through its classified activity in Pharmaceuticals. The…
RHY.AX has an equal number of basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities at present. However, the liquidity risk could not be assessed…
Solid Biosciences Inc is a biotechnology company operating in the Health Care sector, generating limited revenue of $8.09 million while incurring significant operating losses as it advances its dev…
Sonida Senior Living Inc operates in the health care providers and services sector, generating revenue through senior living operations, though specific product details are not disclosed in the ava…
Takeda Pharmaceutical Co Ltd is a global pharmaceutical company that generates revenue through the development and commercialization of prescription medicines. The company is classified in the Phar…
Zenas Biopharma Inc is a biotechnology company operating in the pharmaceuticals sector, generating revenue through its biopharmaceutical activities. The company is classified under the Pharmaceutic…
Zhengye Biotechnology has a market capitalization of 28.24 million USD, based on a market price of 0.95 USD per share and 29.73 million shares outstanding. The company's liquidity risk could not be…
G2GBio Inc has a market capitalization of KRW 1.05 trillion, with a market price of KRW 63,700 per share. The company has no dilution risk, as shares outstanding remain unchanged between basic and…
Perfect Medical Industry Co Ltd has a market capitalization of TWD 1,239,981,000, with a market price of TWD 22.2 per share. The company has 55,855,000 basic and diluted shares outstanding, indicat…
Anxo Pharmaceutical Co Ltd has a market capitalization of TWD 988.9 million, with a market price of TWD 17.7 per share. The company has no dilution risk, as basic and diluted shares outstanding are…
Remus Pharmaceuticals has a fully diluted share count of 11,784,000 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or conver…
Mezoo Co Ltd has a fully diluted share count of 9,717,750, matching its basic share count, indicating no dilution from stock options or convertible instruments. However, liquidity risk could not be…
RecensMedical Inc has a market capitalization of 306.52 billion KRW, with a market price of 28,250 KRW per share. The company has 10,850,298 basic and diluted shares outstanding, indicating no imme…
aetherAI's capital structure is characterized by a market cap of TWD 2.71 billion, with 88.86 million shares outstanding, both basic and diluted, indicating no immediate dilution pressure. The comp…
Horien Biochemical Technology Co Ltd has a market capitalization of 1,680,000,000 TWD, with a market price of 42.0 TWD per share. The company has 40,000,000 basic and diluted shares outstanding, in…
Anlon Healthcare Ltd has an equal number of basic and diluted shares outstanding, with 531,515,000 shares in both categories, indicating no dilution from stock options or convertible securities. Ho…
Onco-Innovations has a fully diluted share count of 59,565,858 shares, with no difference between basic and diluted shares, indicating no dilution risk from stock options or convertible securities.…
TempraMed Technologies Ltd has a fully diluted share count of 78,379,609 shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or c…
Arts Optical International Holdings Ltd has a basic and diluted share count of 386,263,374, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be asses…
The company's capital structure is characterized by a market price of 3.48 and a market cap of 1988213324.64, with a price-to-book ratio of 6.48 and a debt-to-equity ratio of 0.41, indicating a rel…
Vigonvita Life Sciences has a fully diluted share count of 167,597,800 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or converti…
Meribank Biotech has a market capitalization of TWD 1,290,877,200, with a market price of TWD 13.45 per share. The company has 95,976,000 basic and diluted shares outstanding, indicating no immedia…
Basma Adeem Medical Company SCJSC has a capital structure with 20,000,000 basic and diluted shares outstanding, indicating no immediate dilution pressure from share issuance. However, the liquidity…
European Medical Solutions SA has a basic share count of 4,231,839 and a diluted share count of 4,231,839, indicating no dilution from potential equity instruments. The company's liquidity position…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.